Looking to publish in CNS Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCNS Drugs provides researchers and healthcare professionals with information on drug therapies for the management of neurological and psychiatric disorders. The journal publishes reviews and original research articles addressing pharmacology, efficacy, adverse effects, newly developed drugs and drug classes, therapeutic implications of research into disease aetiology, and practical management of specific clinical situations.
Looking to publish in CNS Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
CNS Drugs accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Narrative Reviews
Therapy In Practice
Letter To The Editor
Research Letter
Recent Publications
Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms
Alana King, Morgan Hardy, Taeho Greg Rhee, Samuel T. Wilkinson
Opioid Add-On Combination Therapy for Cancer Pain: Pharmacological Rationale, Clinical Evidence, and Future Directions
Sebastiano Mercadante
Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis
Shakila Meshkat, Marco Leung, Sarina Meshkat, Qiaowei Lin, Dillani Wijendran, Amy C. Reichelt, Yanbo Zhang, Lisa Burback, Olga Winkler, Andrew Greenshaw, Candice M. Monson, Eric Vermetten, Rakesh Jetly, Wendy Lou, Richard J. Zeifman, Venkat Bhat
Candidate Clinico-Demographic Predictors or Moderators of Efficacy and Tolerability of Pharmacological Treatment in Attention-Deficit/Hyperactivity Disorder (ADHD): An Analysis of the MED-ADHD Repository of Randomised Controlled Trials
Sulagna Roy, Guilherme Fusetto Veronesi, Sara Mannarini, Daniele Pirolo, Alessio Bellato, Samuele Cortese, Valeria Parlatini
Heterogeneity in Teriflunomide Treatment Arms: A Systematic Review and Meta‑Regression of Randomised Multiple Sclerosis Trials
Francesca Bovis, Alessio Signori, Mirko Capanna, Noemi Montobbio, Maria Pia Sormani
Frequently asked questions
How long does it take to publish?
Articles are published online after receipt of the corrected proofs.
Reformat to CNS Drugs using Livewrite PremiumIs a cover letter required?
A covering letter should be included with submission and should state the article type, why the paper is important, what is covered in the review or found in the study, why it would interest the journal readership, and any other pertinent information. If the manuscript was previously reviewed by another journal, prior editorial or referee comments and the response to them should also be provided.
Reformat to CNS Drugs using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4190.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC.
Reformat to CNS Drugs using Livewrite Premium